Physician

Rick Whiles, MD

According to 2025 Medicare claims, Rick Whiles, MD (NPI: 1013911874) practices pediatric medicine in the Kingsport-Bristol, TN-VA market, with the plurality of this provider's patient population coming from Sullivan, TN. This provider's primary affiliated billing organization is HOLSTON MEDICAL GROUP PC (NPI: 1831110667; TIN: 621388079) and primary practice location at 37620-7347. Whiles is affiliated with the Emergent ACO, LLC (ACO ID: A4556), participating under the MSSP model.

Whiles' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,366 traditional Medicare patients, billed 122,005 HCPCS/CPT codes, and received $827,211 in Medicare payments. The top billing code was 74177 (Ct scan of abdomen and pelvis with contrast). Part D data shows 9,156 prescription claims across 537 beneficiaries totaling $567,623 in drug costs, led by Eliquis (Apixaban). DME data shows 106 claims. Open Payments data shows 40 records totaling $37,143. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $98,987 to $827,211. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $22,166 and ending at $7,387.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	491	4,118	$98,987
2016	2,402	29,947	$457,631
2017	2,214	32,223	$461,043
2018	2,288	36,263	$486,756
2019	2,888	50,968	$630,126
2020	2,971	60,315	$662,742
2021	3,197	69,040	$768,581
2022	3,000	83,761	$662,883
2023	3,020	96,809	$674,128
2024	3,366	122,005	$827,211

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	331	8,238	$431,666
2016	349	7,963	$461,694
2017	378	7,889	$501,294
2018	371	7,604	$515,566
2019	390	7,068	$524,502
2020	428	7,675	$561,515
2021	443	7,891	$533,047
2022	475	8,046	$506,907
2023	507	8,463	$510,233
2024	537	9,156	$567,623

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	33	261	$14,091
2016	31	194	$6,574
2017	26	278	$7,293
2018	N/R	197	$4,706
2019	23	152	$4,058
2020	25	175	$7,304
2021	38	165	$6,999
2022	N/R	84	$5,569
2023	N/R	115	$6,429
2024	N/R	106	$3,731

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
74177	Ct scan of abdomen and pelvis with contrast	296	309	$214
77067	Screening mammography	1,008	1,008	$118
77063	Screening 3d breast mammography	750	750	$49
77080	Dxa bone density measurement of hip, pelvis, spine	493	493	$36
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	614	60,696	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	53	3,210	$59,897
Jardiance	Empagliflozin	52	2,455	$47,601
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	47	1,890	$39,686
Rybelsus	Semaglutide	11	990	$31,578
Mounjaro	Tirzepatide	26	840	$30,982

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	30	$1,984
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	22	$577
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	11	$569
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	19	$218
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	13	$197

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$567	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$36,576	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rick Whiles, MD?

Tedicare shows public-source Medicare data for Rick Whiles, MD (NPI 1013911874), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rick Whiles, MD have ACO affiliation data?

Rick Whiles, MD is shown with ACO affiliation data for Emergent ACO, LLC (MSSP, ACO ID A4556).

What billing organization is linked to Rick Whiles, MD?

Rick Whiles, MD is linked to HOLSTON MEDICAL GROUP PC (billing NPI 1831110667) in the available physician profile data.

Does Rick Whiles, MD have Open Payments data?

Rick Whiles, MD has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.